Cargando…

Developing an adapted Charlson comorbidity index for ischemic stroke outcome studies

BACKGROUND: The Charlson comorbidity index (CCI) is commonly used to adjust for patient casemix. We reevaluated the CCI in an ischemic stroke (IS) cohort to determine whether the original seventeen comorbidities and their weights are relevant. METHODS: We identified an IS cohort (N = 6988) from the...

Descripción completa

Detalles Bibliográficos
Autores principales: Hall, Ruth E., Porter, Joan, Quan, Hude, Reeves, Mathew J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6892203/
https://www.ncbi.nlm.nih.gov/pubmed/31796024
http://dx.doi.org/10.1186/s12913-019-4720-y
_version_ 1783475983104344064
author Hall, Ruth E.
Porter, Joan
Quan, Hude
Reeves, Mathew J.
author_facet Hall, Ruth E.
Porter, Joan
Quan, Hude
Reeves, Mathew J.
author_sort Hall, Ruth E.
collection PubMed
description BACKGROUND: The Charlson comorbidity index (CCI) is commonly used to adjust for patient casemix. We reevaluated the CCI in an ischemic stroke (IS) cohort to determine whether the original seventeen comorbidities and their weights are relevant. METHODS: We identified an IS cohort (N = 6988) from the Ontario Stroke Registry (OSR) who were discharged from acute hospitals (N = 100) between April 1, 2012 and March 31, 2013. We used hospital discharge ICD-10-CA data to identify Charlson comorbidities. We developed a multivariable Cox model to predict one-year mortality retaining statistically significant (P < 0.05) comorbidities with hazard ratios ≥1.2. Hazard ratios were used to generate revised weights (1–6) for the comorbid conditions. The performance of the IS adapted Charlson comorbidity index (ISCCI) mortality model was compared to the original CCI using the c-statistic and continuous Net Reclassification Index (cNRI). RESULTS: Ten of the 17 Charlson comorbid conditions were retained in the ISCCI model and 7 had reassigned weights when compared to the original CCI model . The ISCCI model showed a small but significant increase in the c-statistic compared to the CCI for 30-day mortality (c-statistic 0.746 vs. 0.732, p = 0.009), but no significant increase in c-statistic for in-hospital or one-year mortality. There was also no improvement in the cNRI when the ISCCI model was compared to the CCI. CONCLUSIONS: The ISCCI model had similar performance to the original CCI model. The key advantage of the ISCCI model is it includes seven fewer comorbidities and therefore easier to implement in situations where coded data is unavailable.
format Online
Article
Text
id pubmed-6892203
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-68922032019-12-11 Developing an adapted Charlson comorbidity index for ischemic stroke outcome studies Hall, Ruth E. Porter, Joan Quan, Hude Reeves, Mathew J. BMC Health Serv Res Research Article BACKGROUND: The Charlson comorbidity index (CCI) is commonly used to adjust for patient casemix. We reevaluated the CCI in an ischemic stroke (IS) cohort to determine whether the original seventeen comorbidities and their weights are relevant. METHODS: We identified an IS cohort (N = 6988) from the Ontario Stroke Registry (OSR) who were discharged from acute hospitals (N = 100) between April 1, 2012 and March 31, 2013. We used hospital discharge ICD-10-CA data to identify Charlson comorbidities. We developed a multivariable Cox model to predict one-year mortality retaining statistically significant (P < 0.05) comorbidities with hazard ratios ≥1.2. Hazard ratios were used to generate revised weights (1–6) for the comorbid conditions. The performance of the IS adapted Charlson comorbidity index (ISCCI) mortality model was compared to the original CCI using the c-statistic and continuous Net Reclassification Index (cNRI). RESULTS: Ten of the 17 Charlson comorbid conditions were retained in the ISCCI model and 7 had reassigned weights when compared to the original CCI model . The ISCCI model showed a small but significant increase in the c-statistic compared to the CCI for 30-day mortality (c-statistic 0.746 vs. 0.732, p = 0.009), but no significant increase in c-statistic for in-hospital or one-year mortality. There was also no improvement in the cNRI when the ISCCI model was compared to the CCI. CONCLUSIONS: The ISCCI model had similar performance to the original CCI model. The key advantage of the ISCCI model is it includes seven fewer comorbidities and therefore easier to implement in situations where coded data is unavailable. BioMed Central 2019-12-03 /pmc/articles/PMC6892203/ /pubmed/31796024 http://dx.doi.org/10.1186/s12913-019-4720-y Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Hall, Ruth E.
Porter, Joan
Quan, Hude
Reeves, Mathew J.
Developing an adapted Charlson comorbidity index for ischemic stroke outcome studies
title Developing an adapted Charlson comorbidity index for ischemic stroke outcome studies
title_full Developing an adapted Charlson comorbidity index for ischemic stroke outcome studies
title_fullStr Developing an adapted Charlson comorbidity index for ischemic stroke outcome studies
title_full_unstemmed Developing an adapted Charlson comorbidity index for ischemic stroke outcome studies
title_short Developing an adapted Charlson comorbidity index for ischemic stroke outcome studies
title_sort developing an adapted charlson comorbidity index for ischemic stroke outcome studies
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6892203/
https://www.ncbi.nlm.nih.gov/pubmed/31796024
http://dx.doi.org/10.1186/s12913-019-4720-y
work_keys_str_mv AT hallruthe developinganadaptedcharlsoncomorbidityindexforischemicstrokeoutcomestudies
AT porterjoan developinganadaptedcharlsoncomorbidityindexforischemicstrokeoutcomestudies
AT quanhude developinganadaptedcharlsoncomorbidityindexforischemicstrokeoutcomestudies
AT reevesmathewj developinganadaptedcharlsoncomorbidityindexforischemicstrokeoutcomestudies